IN2013MU03145A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03145A
IN2013MU03145A IN3145MU2013A IN2013MU03145A IN 2013MU03145 A IN2013MU03145 A IN 2013MU03145A IN 3145MU2013 A IN3145MU2013 A IN 3145MU2013A IN 2013MU03145 A IN2013MU03145 A IN 2013MU03145A
Authority
IN
India
Prior art keywords
abacavir
crystalline
present
hydrochloride
hydrochloride monohydrate
Prior art date
Application number
Other languages
English (en)
Inventor
Girij Pal Singh
Dhananjal Srivastava
Paramvir Bhadwal
Inamus Saqlain Ansari
Sudhakar Patil
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to EP14793623.1A priority Critical patent/EP3052499B1/en
Priority to IN3145MU2013 priority patent/IN2013MU03145A/en
Priority to ES14793623.1T priority patent/ES2651854T3/es
Priority to PCT/IB2014/064890 priority patent/WO2015049623A1/en
Publication of IN2013MU03145A publication Critical patent/IN2013MU03145A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3145MU2013 2013-10-03 2014-09-27 IN2013MU03145A (sk)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP14793623.1A EP3052499B1 (en) 2013-10-03 2014-09-27 Crystalline abacavir hydrochloride monohydrate and process for its preparation
IN3145MU2013 IN2013MU03145A (sk) 2013-10-03 2014-09-27
ES14793623.1T ES2651854T3 (es) 2013-10-03 2014-09-27 Clorhidrato de abacavir monohidrato cristalino y procedimiento para su preparación
PCT/IB2014/064890 WO2015049623A1 (en) 2013-10-03 2014-09-27 Crystalline abacavir hydrochloride monohydrate and process for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3145MU2013 IN2013MU03145A (sk) 2013-10-03 2014-09-27

Publications (1)

Publication Number Publication Date
IN2013MU03145A true IN2013MU03145A (sk) 2015-07-03

Family

ID=51862486

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3145MU2013 IN2013MU03145A (sk) 2013-10-03 2014-09-27

Country Status (4)

Country Link
EP (1) EP3052499B1 (sk)
ES (1) ES2651854T3 (sk)
IN (1) IN2013MU03145A (sk)
WO (1) WO2015049623A1 (sk)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
EP2305680A3 (en) * 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol

Also Published As

Publication number Publication date
EP3052499A1 (en) 2016-08-10
EP3052499B1 (en) 2017-11-15
ES2651854T3 (es) 2018-01-30
WO2015049623A1 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EP3009516A4 (en) Method for preparing sialic acid derivative
HUE045969T2 (hu) Eljárás hialuronsavat és mepivakain-hidrokloridot tartalmazó készítmények elõállítására
ZA201508898B (en) Process for preparing acrylic acid with high space-time yield
EP2999688A4 (en) Process to prepare levulinic acid
EP2970083A4 (en) Process to prepare levulinic acid
SG10201701747YA (en) Method for isolating rna including small rna with high yield
IN2015DN01166A (sk)
PH12016500913A1 (en) Soap bar
EP2703417A4 (en) NEW POLYVINYLSULPHONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
EP2759547A4 (en) PLATIN CONNECTION WITH AMINO OR ALKYLAMINE-CONTAINING AMMONIC ACID DERIVATIVES AS A SUBSTITUTE GROUP, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
IN2014DN09451A (sk)
IN2013MU04056A (sk)
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
EP2882291A4 (en) IMPROVED PROCESS FOR THE PREPARATION OF MELMANTIN CHLORHYDRATE
IN2013MU03145A (sk)
HK1199264A1 (en) Stable crystalline monohydrate of epirubicin hydrochloride and method of production
IL218764A0 (en) Crystalline levofolinic acid and process for its preparation
EP2692721A4 (en) DIAMOND COMPOUND WITH A SULFURIC ACID GROUP AND METHOD OF MANUFACTURING THEREOF
IN2013MU01217A (sk)
EP3055283A4 (en) Process to prepare levulinic acid
IN2013MU00777A (sk)